Evaluation of an Investigational Lubricant Eye Drop on Lipid Layer Thickness
NCT01066988 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2016-11-18
Summary
The purpose of this study is to evaluate the effects of an investigational lubricant eye drop on tear film lipid layer thickness of dry eye patients.
Conditions
- Dry Eye
Interventions
- OTHER
-
ORB Ocular Emulsion
lubricant eye drop
- OTHER
-
SootheXP Emollient (Lubricant) Eye Drops
lubricant eye drop
Sponsors & Collaborators
-
Alcon Research
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-01-31
- Primary Completion
- 2010-02-28
Countries
- United States
Study Locations
More Related Trials
-
Effect of Lipid Based Eye Drops on Tear Film Lipid Layer Thickness
NCT03399292 ·Status: COMPLETED
-
Tear Lipid Layer Thickness Assessments With Perfluorohexyloctane Eye Drops
NCT05288582 ·Status: COMPLETED ·Phase: NA
-
Tear Film Break-Up Time Evaluation of FID 114657
NCT01023464 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Acceptability of Two Lubricant Eye Drops
NCT00756678 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Anti-Inflammatory Treatment in Dry Eye Patients
NCT01276223 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Evaluation Pilot Study of the Efficacy of Blink® Tears Lubricant Eye Drops for the Relief of Dry Eye Symptoms Following Implantation of Tecnis® Multifocal Introcular Lens
NCT01061268 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of the Tolerability and Efficacy of CWT-f-002 Lubricant Eye Drops
NCT05660681 ·Status: COMPLETED ·Phase: NA
-
A Clinical Evaluation of an Investigational Lubricant Eye Gel (FID 115958D)
NCT01294956 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Safety and Tolerability of Investigational Ocular Lubricants
NCT05888519 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy Study of New Eye Drop Formulations With Refresh Tears® in Patients With Dry Eye Disease
NCT01294384 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Evaluating the Efficacy and Safety of RCI001 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye
NCT07068958 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Evaluation of SYSTANE® BALANCE in Dry Eye Subjects With Lipid Deficiency
NCT01688726 ·Status: COMPLETED ·Phase: NA
-
Evaluation of FID 114657 in Sjogren's Syndrome Subjects
NCT01079871 ·Status: COMPLETED ·Phase: NA
-
Lipid Layer Thickness Pre and Post Lid Scrubs With Cliradex
NCT02493244 ·Status: COMPLETED ·Phase: NA
-
The Effect of SYSTANE® BALANCE on Tear Film Break Up Time in Dry Eye Subjects
NCT01718028 ·Status: COMPLETED ·Phase: NA
-
A Study of AL-38583 Ophthalmic Solution 0.05%, 0.010% Versus AL-38583 Vehicle for Dry Eye
NCT00893139 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Outcomes Following Treatment With Systane® Balance in Dry Eye Subjects
NCT01967147 ·Status: COMPLETED ·Phase: NA
-
Evaluation of FID 114657 in Dry Eye Subjects
NCT01079858 ·Status: COMPLETED ·Phase: NA
-
A Study to Compare the Safety and Efficacy of A New Eye Drop Formulation With OPTIVE™ in Subjects With Dry Eye Disease
NCT01664949 ·Status: COMPLETED ·Phase: PHASE3
-
A Safety, Tolerability and Pharmacokinetics Study of R932348 Eye Drops in Patients With Dry Eye Disease
NCT01733992 ·Status: COMPLETED ·Phase: PHASE1
-
Lifitegrast 5% Ophthalmic Solution and Contact Lens Dryness
NCT03686878 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of the Chronic Application of Tear Formulations
NCT01384851 ·Status: UNKNOWN ·Phase: NA
-
Study of TOP1630 for Dry Eye Syndrome
NCT03833388 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Evaluation of the Safety and Tolerability of Ocular Lubricants
NCT06571656 ·Status: TERMINATED ·Phase: NA
-
Artificial Tears, Tear Lipids and Tear Film Dynamics
NCT05705518 ·Status: COMPLETED ·Phase: PHASE4